1,001 top medical experts on Amyloidosis across 44 countries and 38 U.S. states, including 969 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Amyloidosis: A group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of amyloid. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Proteostasis Deficiencies (809) and Narrower Categories: Amyloid Neuropathies (230), Cerebral Amyloid Angiopathy (565), Familial Amyloidosis (758), Immunoglobulin Light-chain Amyloidosis (1,030).
  4. Clinical Trials ClinicalTrials.gov : at least 264 including 21 Active, 128 Completed, 56 Recruiting


  

        

                    


    Computing Expert Listing ...

);